US Patent Issued to XIYUAN ANJIAN MEDICINE (SHANGHAI) on March 31 for "Anti-trka antibody or antigen-binding fragment thereof, preparation method thereof, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,158, issued on March 31, was assigned to XIYUAN ANJIAN MEDICINE (SHANGHAI) Co. LTD (Shanghai).

"Anti-trka antibody or antigen-binding fragment thereof, preparation method thereof, and application thereof" was invented by Xiaohui Yuan (Shanghai), Guoyong Wang (Shanghai), Yujiao Liu (Shanghai) and Donghong Zheng (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an anti-TrkA antibody or an antigen-binding fragment thereof, a preparation method, and an application thereof. The present invention also provides an isolated polynucleotide encoding the anti-TrkA antibody or the antigen-binding fragments thereof, and a v...